University of Florida Health

University of Florida Health

Contact Information

 UF Center for Movement Disorders & Neurorestoration, 3450 Hull Road, 4th Floor, Gainesville, FL 32607

(352) 294-5400

Site Coordinator


Kyle Ryzer


Erin Monari, PhD

Site Investigator

Nikolaus McFarland, MD, PhD

Nikolaus McFarland, MD, PhD, holds The Wright/Falls/Simmons Professorship in PSP/Atypical Parkinson’s and is Chief of the Movement Disorders Division at the University of Florida (UF). He joined the UF Department of Neurology and the UF Health Center for Movement Disorders and Neurorestoration in 2010. He graduated from the University of Chicago in 1992 with honors and election into the Sigma Xi research society. He completed medical and graduate training in the MD/PhD program at the University of Rochester School of Medicine & Dentistry, where he received a merit award for outstanding graduate research in thalamic and basal ganglia anatomy. Afterward, he went to the University of Virginia for internship and residency training in neurology, followed by fellowship training in movement disorders at the Massachusetts General Hospital in Boston. There, he also pursued research in Parkinson disease and related disorders at the Mass General Institute for Neurodegenerative Disease. As a Udall Fellow, he was the first recipient of the Robert Koch Parkinson Disease research fellowship and was awarded foundation support from both the American Parkinson Disease Association and Michael J. Fox Foundation for his research. He has since been funded by the National Institutes of Health. Dr. McFarland is a member of the Center for Translational Research in Neurodegenerative Disease at the University of Florida, which aims to bring the bench closer to the bedside. His research focuses on understanding the pathological mechanisms of Parkinson disease and related neurodegenerative disorders. His research utilizes both cellular and preclinical models to study genes and molecules that cause brain diseases. A primary goal of his research is to identify and to develop potential novel therapeutics for Parkinson disorders. In addition, Dr. McFarland has strong clinical interests in Huntington disease, Parkinson disease, and Atypical Parkinsonisms (Parkinson-plus syndromes), such as progressive supranuclear palsy (PSP) and multiple system atrophy (MSA). He and one of his research partners, Chris Hass, PhD, direct an exciting multidisciplinary clinical-research program for PSP and atypical Parkinson’s disease through the support of the Allen’s and several other afflicted families. He is also member of the HSG and Director of the UF Huntington disease (HDSA) Center of Excellence, providing comprehensive care and research opportunities for Huntington disease patients.